Volume 14, Number 10—October 2008
Research
Prophylaxis after Exposure to Coxiella burnetii
Table 3
Total medical cases averted because of postexposure prophylaxis*
Population | No. cases averted |
---|---|
General population | |
All cases of illness | 39,990 |
Severe illness | 10,650 |
Deaths |
480 |
High-risk population | |
All cases of illness | 39,990 |
Severe illness | 29,510 |
Deaths |
3,538 |
Pregnant women† | |
All cases of illness | 66,210 |
Severe illness | 53,300 |
Deaths | 22,394 |
*Accounting for best estimate drug-related adverse events, 82% drug efficacy, and 100% exposure.
†Includes the outcome of the unborn child.